Why women choose at-home abortion via teleconsultation in France: Drivers of telemedicine abortion during and beyond the COVID-19 pandemic

17Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives In an attempt to understand the demand and main drivers of telemedicine abortion, we analysed the requests that Women on Web (WoW), an online telemedicine abortion service operating worldwide, received from France throughout 2020. Methods We conducted a parallel, convergent, mixed-methods study among 809 consultations received from France at WoW between 1 January and 31 December 2020. We performed a cross-sectional study of data obtained from the WoW consultation survey and a manifest content analysis of anonymised email correspondence of 140 women consulting with the WoW helpdesk from France. Findings We found that women encounter macro-level, individual-level and provider-level constraints while trying to access abortion in France. The preferences and needs over secrecy (n=356, 46.2%), privacy (n=295, 38.3%) and comfort (n=269, 34.9%) are among the most frequent reasons for women from France to choose telemedicine abortion through WoW. The COVID-19 pandemic seems to be an important driver for resorting to telemedicine (n=236, 30.6%). The lockdowns had a significant impact on the number of consultations received at WoW from France, increasing from 60 in March to 128 in April during the first lockdown and from 54 in October to 80 in November during the second lockdown. Conclusions The demand for at-home medical abortion via teleconsultation increased in France during the lockdowns. However, drivers of telemedicine abortion are multidimensional and go beyond the conditions unique to the pandemic.

Cite

CITATION STYLE

APA

Atay, H., Perivier, H., Gemzell-Danielsson, K., Guilleminot, J., Hassoun, D., Hottois, J., … Levrier, E. (2021). Why women choose at-home abortion via teleconsultation in France: Drivers of telemedicine abortion during and beyond the COVID-19 pandemic. BMJ Sexual and Reproductive Health, 47(4), 285–292. https://doi.org/10.1136/bmjsrh-2021-201176

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free